United Kingdom

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

22 Apr 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Chirayu Amin

66 2016 Executive Chairman of the Board, Chief Executive Officer

Rajkumar Baheti

54 2014 Chief Financial Officer, Director - Finance, Executive Director

Ajay Desai

2018 Head of Osteofit and Ouron Divisions, Senior Vice President - Finance

Charandeep Saluja

2018 Compliance Officer, Company Secretary

Pranav Amin

38 2016 Managing Director, Executive Director